Gepirone API (CAS No. 83928-76-1) is a synthetic serotonergic active pharmaceutical ingredient associated with antidepressant, central nervous system, and major depressive disorder pharmaceutical development.
Gepirone belongs to the azapirone class of serotonergic pharmaceutical compounds and is structurally associated with arylpiperazine-based central nervous system agents.
Gepirone is a selective serotonin 5-HT1A receptor agonist. Its antidepressant activity is thought to be associated with modulation of serotonergic signaling within the central nervous system through activity at 5-HT1A receptors.
The pharmacological activity of Gepirone is associated with the parent compound and its major active metabolites, including 3'-hydroxygepirone and 1-(2-pyrimidinyl)piperazine, commonly abbreviated as 1-PP.
Gepirone and the 3'-hydroxy metabolite interact with 5-HT1A receptors, while the 1-PP metabolite is associated with alpha-2 adrenergic receptor binding.
Gepirone is associated with a differentiated antidepressant mechanism compared with conventional selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors because its primary pharmacological action is related to selective serotonergic receptor agonism rather than serotonin reuptake inhibition.
Pharmaceutical companies sourcing Gepirone API commonly evaluate assay, HPLC purity, related substances, process-related impurities, degradation products, residual solvents, water content, crystalline characteristics, particle size distribution, and batch-to-batch consistency.
Gepirone free base and Gepirone Hydrochloride should be treated as separate pharmaceutical material identities. The hydrochloride salt is the pharmaceutical material form associated with extended-release oral tablet products.
Because Gepirone-related pharmaceutical products are associated with extended-release oral dosage forms, API physical characteristics such as particle size distribution, crystal form, bulk density, powder flow, and formulation compatibility may be important during pharmaceutical development.
Swapnroop Drugs and Pharmaceuticals supplies Gepirone API for qualified pharmaceutical research, antidepressant drug development, central nervous system formulation development, analytical, generic pharmaceutical research, and regulated manufacturing requirements with product-specific quality documentation, pharmaceutical-grade packaging, and reliable supply-chain coordination.
Get Bulk Quote via WhatsApp